编辑委员会对放射化学和放射性药物发展的重点选择。

Highlight selection of radiochemistry and radiopharmacy developments by editorial board.

作者信息

Toyohara Jun, Al-Qahtani Mohammed, Huang Ya-Yao, Cazzola Emiliano, Todde Sergio, Furumoto Shozo, Mikolajczak Renata, Decristoforo Clemens, Gillings Nic, Yang Min, Reilly Raymond, Duatti Adriano, Denkova Antonia, Schirrmacher Ralf, Carlucci Giuseppe, Seimbille Yann, Liu Zhaofei, Ellis Beverley, Cornelissen Bart T, Kopka Klaus, Bernardes Emerson

机构信息

PET Radiopharmaceutical Sciences, Research Team for Neuroimaging, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan.

Cyclotron and Radiopharmaceuticals Department, King Faisal Specialist Hospital and Research Center (KFSHRC), Riyadh, Saudi Arabia.

出版信息

EJNMMI Radiopharm Chem. 2022 Oct 1;7(1):25. doi: 10.1186/s41181-022-00177-w.

DOI:10.1186/s41181-022-00177-w

PMID:36182995

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9526771/

Abstract

BACKGROUND

The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development.

MAIN BODY

This commentary of highlights has resulted in 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals.

CONCLUSION

Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field in various topics including new PET-labelling methods, FAPI-tracers and imaging, and radionuclide therapy being the scope of EJNMMI Radiopharmacy and Chemistry.

摘要